Skip to main content
. Author manuscript; available in PMC: 2024 Nov 18.
Published in final edited form as: Urol Oncol. 2021 Mar 4;39(10):731.e17–731.e24. doi: 10.1016/j.urolonc.2021.02.008

Table 1.

Characteristics of study population

Characteristic Any high-intensity end-of-life care (n = 2,728) No high-intensity end-of-life care (n = 3,338) p-value

Age (%) <0.001
 66–69 301 (11.0) 283 (8.5)
 70–74 484 (17.7) 488 (14.6)
 75–79 580 (21.3) 622 (18.6)
 80 and older 1,363 (50.0) 1,945 (58.3)
Sex (%) 0.004
 Male 1,917 (70.3) 2,230 (66.8)
 Female 811 (29.7) 1,108 (33.2)
Race/Ethnicity (%) <0.001
 White 2,275 (83.4) 2,942 (88.1)
 Black 210 (7.7) 165 (4.9)
 Hispanic 131 (4.8) 121 (3.6)
 Asian 90 (3.3) 88 (2.6)
 Other 22 (0.8) 22 (0.7)
Marital status (%) 0.2
 Married 1,354 (49.6) 1,606 (48.1)
 Not married/Unknown 1,235 (45.3) 1,582 (47.4)
Comorbidity (%) <0.001
 0 907 (33.2) 1,248 (37.4)
 1 656 (24.0) 794 (23.8)
 2 387 (14.2) 503 (15.1)
 3 or more 703 (25.8) 636 (19.1)
Education in ZIP code of residence (%) <0.001
 Low: 75% or fewer with high school education 404 (14.8) 387 (11.6)
 High: >75% with high school education 2258 (82.8) 2890 (86.6)
 Missing/Unknown 66 (2.4) 61 (1.8)
Population of county of residence (%) 0.02
 249,999 or less 720 (26.4) 976 (29.2)
 250,000–999,999 477 (17.5) 612 (18.3)
 1,000,000 or more 1,531 (56.1) 1,750 (52.4)
Median income in ZIP code of residence, $ (%) 0.2
 40,000 or less 523 (19.2) 585 (17.5)
 40,0001–60,000 991 (36.3) 1,269 (38.0)
 60,001 or more 1,147 (42.0) 1,419 (42.5)
 Missing/Unknown 67 (2.5) 65 (1.9)
Geographic region (%) 0.001
 Northeast 704 (25.8) 728 (21.8)
 South 643 (23.6) 784 (23.5)
 Central 347 (12.7) 489 (14.6)
 West 1,034 (37.9) 1,337 (40.1)
T stage (%)
 T1 or lower 85 (3.1) 90 (2.7) <0.001
 T2 1,450 (53.2) 1,912 (57.3) <0.001
 T3 865 (31.7) 881 (26.4)
 T4 328 (12.0) 455 (13.6)
N stage (%) 0.1
 N0/NX 2,311 (74.7) 2,877 (86.2)
 N+ 417 (15.3) 461 (13.8)
M stage (%) 0.1
 M0/MX 2,239 (82.2) 2,792 (83.6)
 M+ 489 (17.9) 546 (16.4)
Extent of disease <0.001
 Advanced (T4, or N+, or M+) 1,960 (71.8) 2,456 (73.6)
 Localized (all except T4/N+/M+) 440 (16.1) 427 (12.8)
Receipt of palliative care (%) 139 (5.1) 125 (3.7%) <0.001
Diagnosis to palliative care in months, median (IQR) 8.2 (3.2—16.5) 6.4 (2.2—14.7) 0.1
Palliative care to death in months, median (IQR) 0.9 (0.2—3.3) 2.3 (1.0—6.3) <0.001
Cause of death (%) <0.001
 Bladder cancer 1,378 (50.5) 1,857 (55.6)
 Other 1,350 (49.5) 1,481 (44.4)
Year of diagnosis (%) 0.1
 2008 537 (19.7) 609 (18.2)
 2009 510 (18.7) 579 (17.3)
 2010 498 (18.3) 589 (17.6)
 2011 452 (16.6) 579 (17.3)
 2012 411 (15.1) 528 (15.8)
 2013 320 (11.7) 454 (13.6)

Percentages may not sum to 100 due to rounding.

Advanced stage defined as stage T4 and/or N1 and/or M1.